Ghent University Academic Bibliography

Does nivolumab for progressed metastatic lung cancer fulfill its promises? : an efficacy and safety analysis in 20 general hospitals

Kurt Tournoy (UGent) , Michiel Thomeer, Paul Germonpré, Sofie Derijcke, Rebecca De Pauw, Daniëlla Galdermans, Karl Govaert, Elke Govaerts, Rob Schildermans, Isabelle Declercq, et al.

(2018) LUNG CANCER. 115. p.49-55

Add to list

Journal Article
A1
open access

Inhaled treatment of COPD : a Delphi consensus statement

Vincent Ninane, Jean-Louis Corhay, Paul Germonpre, Wim Janssens, Guy Joos (UGent) , Giuseppe Liistro, Walter Vincken, Sandra Gurdain, Evelyne Vanvlasselaer and An Lehouck

(2017) INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. 12. p.793-801

Add to list

The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor

Kevin Hollevoet (UGent) , Kristiaan Nackaerts, Olivier Thas (UGent) , Joël Thimpont, Paul Germonpré, Paul De Vuyst, Lionel Bosquée, Catherine Legrand, Eliane Kellen, Yoshiro Kishi, et al.

(2012) CHEST. 141(2). p.477-484

Add to list

Preferred and actual involvement of advanced lung cancer patients and their families in end-of-life decision making: a multicenter study in 13 hospitals in Flanders, Belgium

Koen Pardon (UGent) , Reginald Deschepper (UGent) , Robert Vander Stichele (UGent) , Jan L Bernheim, Freddy Mortier (UGent) , Denis Schallier, Paul Germonpre, Daniela Galdermans, Willem Van Kerckhoven and Luc Deliens (UGent)

(2012) JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 43(3). p.515-526

Add to list

Expressed wishes and incidence of euthanasia in advanced lung cancer patients

Koen Pardon (UGent) , Reginald Deschepper (UGent) , Robert Vander Stichele (UGent) , Jan L Bernheim, Freddy Mortier (UGent) , Denis Schallier, Paul Germonpre, Daniella Galdermans, Willem Van Kerckhoven, Luc Deliens (UGent) , et al.

(2012) EUROPEAN RESPIRATORY JOURNAL. 40(4). p.949-956

Add to list

Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma

Kevin Hollevoet (UGent) , Kristiaan Nackaerts, Robert Gosselin (UGent) , Walter De Wever, Lionel Bosquée, Paul De Vuyst, Paul Germonpré, Eliane Kellen, Catherine Legrand, Yoshiro Kishi, et al.

(2011) JOURNAL OF THORACIC ONCOLOGY. 6(11). p.1930-1937

Add to list

Are patients' preferences for information and participation in medical decision-making being met?: interview study with lung cancer patients

Koen Pardon (UGent) , Reginald Deschepper (UGent) , Robert Vander Stichele (UGent) , Jan Bernheim, Freddy Mortier (UGent) , Denis Schallier, Paul Germonpre, Daniella Galdermans, Willem Van Kerckhoven and Luc Deliens (UGent)

(2011) PALLIATIVE MEDICINE. 25(1). p.62-70

Add to list

Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study

Kevin Hollevoet (UGent) , Joris Van Cleemput, Joel Thimpont, Paul De Vuyst, Lionel Bosquee, Kristiaan Nackaerts, Paul Germonpre, Stijn Vansteelandt (UGent) , Yoshiro Kishi, Joris Delanghe (UGent) , et al.

(2011) JOURNAL OF THORACIC ONCOLOGY. 6(5). p.889-895

Add to list

Journal Article
A1
open access

Preferences of patients with advanced lung cancer regarding the involvement of family and others in medical decision-making

Koen Pardon (UGent) , Reginald Deschepper (UGent) , Robert Vander Stichele (UGent) , Jan L Bernheim, Freddy Mortier (UGent) , Nathalie Bossuyt, Denis Schallier, Paul Germonpré, Daniella Galdermans, Willem Van Kerckhoven, et al.

(2010) JOURNAL OF PALLIATIVE MEDICINE. 13(10). p.1199-1203

Add to list

Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma

Kevin Hollevoet (UGent) , Kristiaan Nackaerts, Joel Thimpont, Paul Germonpre, Lionel Bosquee, Paul De Vuyst, Catherine Legrand, Eliane Kellen, Yoshiro Kishi, Joris Delanghe (UGent) , et al.

(2010) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 181(6). p.620-625

Academic Bibliography

Does nivolumab for progressed metastatic lung cancer fulfill its promises? : an efficacy and safety analysis in 20 general hospitals

Inhaled treatment of COPD : a Delphi consensus statement

The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor

Preferred and actual involvement of advanced lung cancer patients and their families in end-of-life decision making: a multicenter study in 13 hospitals in Flanders, Belgium

Expressed wishes and incidence of euthanasia in advanced lung cancer patients

Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma

Are patients' preferences for information and participation in medical decision-making being met?: interview study with lung cancer patients

Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study

Preferences of patients with advanced lung cancer regarding the involvement of family and others in medical decision-making

Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma

Contents

Support

Contact